摘要
目的:探讨盐酸氟桂利嗪预防性治疗偏头痛的有效性及安全性.方法:采用开放性研究,2120例偏头痛患者每日口服盐酸氟桂利嗪5~10 mg,治疗时间为12周,在治疗开始及4周末、8周末、12周末分别记录患者的头痛程度、频率、服药剂量、不良事件发生情况以及血压.结果:治疗后4周末、8周末及12周末与治疗前相比,头痛程度明显减轻(均P<0.05),频率明显减少(均P<0.05),盐酸氟桂利嗪用量亦明显减少(均P<0.05),未发现严重不良事件,治疗前后血压无明显变化(均P>0.05).结论:盐酸氟桂利嗪是一种安全有效的偏头痛预防性治疗药物.
Objective:To explore the efficacy and safety of flunarizine on migraine. Method: 2120 migraineurs took flunarizine ( 5 -10 mg, qd) orally for 12 weeks. The intensity of headache ( VAS), frequency of headache, dosage of fanarizine, adverse events and blood pressure were assessed before treatment and 4, 8, 12 weeks after treatment. Result:Significant difference existed among before treatment and 4, 8, 12 weeks after treatment in VAS, frequency of headache and dosage of flunarizine ( all P 〈 0.05 ). However, the blood pressure showed no significant difference among different time ( all P 〉 0.05 ). Severe adverse events were not found. Conclusion:Flunarizine is safe and effective for the prophylaxis treatment of migraine.
出处
《中国疼痛医学杂志》
CAS
CSCD
北大核心
2007年第4期199-201,共3页
Chinese Journal of Pain Medicine